| Literature DB >> 35328328 |
Frederico Barbosa1,2, Frederico Castelo Ferreira1,2, João Carlos Silva1,2,3.
Abstract
Osteochondral tissue (OCT) related diseases, particularly osteoarthritis, number among the most prevalent in the adult population worldwide. However, no satisfactory clinical treatments have been developed to date to resolve this unmet medical issue. Osteochondral tissue engineering (OCTE) strategies involving the fabrication of OCT-mimicking scaffold structures capable of replacing damaged tissue and promoting its regeneration are currently under development. While the piezoelectric properties of the OCT have been extensively reported in different studies, they keep being neglected in the design of novel OCT scaffolds, which focus primarily on the tissue's structural and mechanical properties. Given the promising potential of piezoelectric electrospun scaffolds capable of both recapitulating the piezoelectric nature of the tissue's fibrous ECM and of providing a platform for electrical and mechanical stimulation to promote the regeneration of damaged OCT, the present review aims to examine the current state of the art of these electroactive smart scaffolds in OCTE strategies. A summary of the piezoelectric properties of the different regions of the OCT and an overview of the main piezoelectric biomaterials applied in OCTE applications are presented. Some recent examples of piezoelectric electrospun scaffolds developed for potentially replacing damaged OCT as well as for the bone or articular cartilage segments of this interfacial tissue are summarized. Finally, the current challenges and future perspectives concerning the use of piezoelectric electrospun scaffolds in OCT regeneration are discussed.Entities:
Keywords: articular cartilage; bone; electrospinning; osteochondral tissue; piezoelectric fibrous scaffolds; tissue engineering
Mesh:
Substances:
Year: 2022 PMID: 35328328 PMCID: PMC8952277 DOI: 10.3390/ijms23062907
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Piezoelectric electrospun fibrous scaffolds for osteochondral tissue engineering applications.
Summary of main dielectric and piezoelectric properties of articular cartilage and cortical and trabecular bone. It should be noted that the values were obtained from different animal models: bovine (*), porcine (*1), and human (*2). Even though research on the topic is scarce, it is important to consider that the piezoelectric properties of bone and cartilage are likely affected by aging and tissue degeneration, given the effects of these factors on the tissues’ ECM composition (collagen degradation) and mechanical properties that have already been reported in the literature [27,28,29].
| Articular Cartilage | Bone | References | ||
|---|---|---|---|---|
| Cortical | Trabecular | |||
| Conductivity (S/m) | 1.14 ± 0.11 * | 0.02 *1 | 0.079 *1 | [ |
| Relative Permittivity | 1.39 × 103 *1 | 1.45 × 102 *1 | 2.49 × 102 *1 | [ |
| Piezoelectric Charge Coefficient, d33 (pC/N) | 0.2–0.7 *2 | 0.7–2.3 *2 | [ | |
Piezoelectric charge coefficient of main piezoceramics applied so far in piezoelectric scaffold-based OCTE strategies.
| Piezoceramics | |||||
|---|---|---|---|---|---|
| Barium Titanate | HAp | Zinc Oxide | Boron Nitride (BNNTs) | KNN/LKNN | |
| Piezoelectric Charge Coefficient, d33 (pC/N) | 191 | 1.5–2.4 | 12.4 | 31.2 (d31) | KNN: 63 |
| References | [ | [ | [ | [ | [ |
Figure 2Piezoceramics used for TE applications [51,52,53,54,55]. It should be noted that the chemical structure of piezoceramics is variable, depending mainly on the fabrication process used. Reproduced from Burns and Dolgos [51] with permission from the Centre National de la Recherche Scientifique (CNRS) and The Royal Society of Chemistry. Reprinted from Espitia et al. [52], Copyright 2012, by permission from Springer Nature. Reprinted with permission from Král et al. [53], Copyright 2000 by the American Physical Society.
Summary of main piezoceramics that have been applied so far in piezoelectric scaffold-based TE strategies.
| Piezoceramics | Advantages | Disadvantages | Applications | References |
|---|---|---|---|---|
| Barium Titanate | High piezoelectric coefficient. | Non-biodegradable. | Bone, Neural, and Skin TE. | [ |
| HAp | Biocompatible. | Difficult to polarize. | Bone TE. | [ |
| Zinc Oxide | Biocompatible. | Cytotoxicity reports (mainly in nanometer-size particles). | Bone and Skin TE. | [ |
| Boron Nitride | High piezoelectric coefficient. | Non-biodegradable. | Bone and Neural TE. | [ |
| KNN/LKNN | High piezoelectric coefficient. | Reports of cytotoxicity. | Bone, Neural, and Skin TE. | [ |
Piezoelectric charge coefficient of main piezoelectric polymers applied so far in piezoelectric scaffold-based OCTE strategies.
| Piezoelectric Polymers | ||||||
|---|---|---|---|---|---|---|
| PVDF/PVDF-TrFE | PLLA | PHB/PHBV | Collagen | Cellulose | Chitosan | |
| Piezoelectric Charge Coefficient, d33 (pC/N) | PVDF: 34 | 9.82 (d14) | PHB: 1.6–2 (d14) | 0.2–2 (d14) | 0.1 (d31) | 2.54 |
| References | [ | [ | [ | [ | [ | [ |
Figure 3Chemical structures of the main piezoelectric polymers used for TE applications.
Figure 4Chemical structures of the most common crystalline phases of PVDF: ((a)—α phase, (b)—β phase, (c)—γ phase) and (d) PVDF-TrFE piezoelectric polymers.
Summary of the main piezoelectric polymers that have been applied so far in scaffold-based TE strategies.
| Piezoelectric Polymers | Advantages | Disadvantages | Applications | References |
|---|---|---|---|---|
| PVDF/PVDF-TrFE | High piezoelectric coefficient. | Non-biodegradable. | Bone, Cartilage, Cardiac, Neural, and Skin TE. | [ |
| PLLA | Biocompatible. | Low piezoelectric coefficient (compared with PVDF and PVDF-TrFE). | Medical devices (e.g., screws, fixation rods). | [ |
| PHB/PHBV | Biocompatible. | Low piezoelectric coefficient. | Bone, Cartilage, and Cardiac TE. | [ |
| Collagen | Biocompatible. | Low piezoelectric coefficient (when compared to synthetic PZPs). | Bone, Cartilage, and Skin TE. | [ |
| Cellulose | Biocompatible. | Very low piezoelectric coefficient. | Bone and Neural TE. | [ |
| Chitosan | Biocompatible. | Low piezoelectric coefficient. | Bone, Cartilage, and Skin TE. | [ |
Examples of piezoceramic or PZP-based electrospun piezoelectric nanofibers described in the literature for bone TE applications.
| Fiber Composition | Brief Description | References |
|---|---|---|
| Barium Titanate/Calcium Phosphates | Casting Solution: Gelatin (70%, wt%) in distilled water | [ |
| Boron Nitride/Gelatin | Casting Solution: Gelatin (20%, wt%) in acetic acid mixed with boron nitride nanoparticles (0.1%, 1% and 5%, wt%) | [ |
| ZnO-fCNTs/Polyurethane | Casting Solution: Polyurethane (PU, 8%, wt%) in DMF/tetrahydrofuran (THF) (1:1) mixed with ZnO nanoparticles (0.2%, wt%) and carbon nanotubes functionalized with carboxylic groups (fCNTs) (0.1%, 0.2% and 0.4%) | [ |
| PVDF-TrFE | Casting Solution: PVDF-TrFE (75/25) (20%, wt%) in DMF/Acetone (3:2) | [ |
| PVDF | Casting Solution: PVDF (15%, wt%) in DMF/Acetone (2:3) | [ |
| PVDF/HAp | Casting Solution: PVDF (16%, wt%) in DMF/Acetone (1:1) mixed with HAp nanoparticles (5% and 10%, wt%) | [ |
| PVDF/HAp | Casting Solution: PVDF (25%, wt%) in DMF/Acetone (3:1) | [ |
| PVDF | Casting Solution: PVDF (22%, wt%) in dimethyl acetamide (DMAC)/Acetone (1:1) | [ |
| PVDF- | Casting Solution: Core—PVDF (27%, wt%) in dimethyl sulfoxide (DMSO)/Acetone (3:2) mixed with barium titanate nanoparticles (1%, 2% and 5%, wt%); Sheath—PVA (15%, wt%) in DMSO/Ethanol (9:1) | [ |
| PHBV/SiHAp | Casting Solution: PHBV (23%, wt%) in chloroform mixed with SiHAp nanoparticles (10%, wt%) | [ |
| PLLA/Barium Titanate | Casting Solution: PLLA in trifluoroethanol mixed with barium titanate nanoparticles (1%, 3%, 5%, 7% and 10%, wt%) | [ |
Examples of piezoceramic or PZP-based electrospun piezoelectric nanofibers described in the literature for articular cartilage (1) and osteochondral (2) TE applications.
| Fiber Composition | Brief Description | References |
|---|---|---|
| PHBV/Barium Titanate (1) | Casting Solution: PHBV (15% and 20%, wt%) in chloroform/methanol (3:2) mixed with barium titanate nanoparticles (5%, 10% and 20%, wt%) | [ |
| PHB/Chitosan (1) | Casting Solution: PHB (9%, wt%) in trifluoroacetic acid (TFA) mixed with chitosan (5%, 10%, 15% and 20%, wt%) | [ |
| PHB/CNT/Chitosan | Casting Solution: PHB (9%, wt%), chitosan (20%, wt%) and carbon nanotubes (CNTs) (1%, wt%) in TFA mixed with hyaluronic acid (HA) (5%, 10% and 15%, wt%) | [ |
| PVDF/PCL (1) | Casting Solution: PCL in DMF/THF (1:1) mixed with PVDF in DMAC/Acetone (1:1) (50:50) | [ |
| PLLA/PCL (1) | Casting Solution: PLLA (12% and 20%, wt%) and PCL (12% and 20%, wt%) in dichloromethane (DCM)/DMF (75:25). Note: Two polymeric concentrations were considered to obtain fibers with different diameters (800 nm and 1.8 μm) | [ |
| ZnO/PCL (2) | Casting Solution: PCL (13%, wt%) in methylene chloride mixed with ZnO nanoparticles (1%, 2.5%, 5% and 10%, wt%) | [ |
| PVDF-TrFE (2) | Casting Solution: PVDF-TrFE (65/35) (25%, wt%) in MEK | [ |
| PLLA/Collagen | Casting Solution: PLLA (3.5%, wt%) in chloroform/ethanol (3:1) | [ |
| P(LLA-CL)/Collagen/Hyaluronan | Casting Solution: P(LLA-CL) (75/25) and type I collagen (8%, wt%) in hexafluoroisopropanol (HFIP) | [ |